Launching a Spravato treatment program takes more than REMS enrollment and a treatment room. A practice also needs trained staff, payer and credentialing readiness, insurance verification, prior authorization workflows, a medication acquisition strategy, and a billing process that works before the first patient walks in.
The programs that succeed build their clinical and financial systems at the same time, instead of treating billing as an afterthought.
At a minimum, your practice should have:
If any of these pieces are missing, your program can be clinically ready and still financially unprepared.
Every healthcare setting must be certified under the SPRAVATO REMS program before administering treatment. That means putting the required treatment, monitoring, documentation, and staffing procedures in place ahead of time.
Patients are monitored for at least two hours after each dose, so your clinic needs enough space, staff, and monitoring capacity to support that. REMS should not be treated as a one-time administrative checkbox. It needs to be built into the practice’s daily workflow.
You do not need a large team to launch a Spravato program, but every responsibility needs an owner. Decide in advance who will manage:
One of the most common mistakes new programs make is piling all of this onto the front desk or clinical team. Prior authorization alone can turn into a heavy administrative burden as patient volume grows.
Before you start marketing the program, find out which payers you can actually treat and get reimbursed by. For each payer, confirm:
Active insurance does not automatically mean Spravato is covered. That is why eligibility and benefits verification needs to happen before treatment is ever scheduled, not after.
Finnastra’s Spravato billing services are built to simplify this front end process and prevent costly surprises once treatment is underway.
Most practices choose between a patient specific pharmacy pathway or an appropriate buy and bill model where it is permitted.
If you are considering buy and bill, understand the economics before you commit. Ask:
Buying medication before you understand payer reimbursement timelines can create a cash flow problem fast.
Eligibility and prior authorization are two of the most important revenue cycle steps in any Spravato program. A strong prior authorization workflow should verify:
Getting the approval is not enough on its own. The authorization has to match the actual treatment and the claim you submit.
As a leading Spravato billing services company, Finnastra manages eligibility, prior authorization, reauthorization, and payer follow-up so practices can move patients into treatment faster.
Do not wait until after the first treatment to figure out billing. Before go-live, your practice should already know:
Many Spravato revenue problems start because the clinical program launches before the billing process is ready. Working with a dedicated Spravato billing company like Finnastra connects eligibility, prior authorization, treatment documentation, coding, claims, and AR into a single workflow, instead of six disconnected steps.
A strong patient journey typically follows this path:
Patient evaluation, insurance verification, prior authorization, REMS requirements, medication coordination, treatment, billing, payment, and reauthorization.
Every step needs a clear owner. The clinical team should not be chasing down payer requirements, and the billing team should not be stuck reconstructing what happened during treatment after the fact.
Finnastra supports practices before launch and after it. We help with:
Our goal is simple: help practices become treatment ready and reimbursement ready at the same time.
Spravato combines a specialty medication, REMS requirements, prior authorization, payer specific rules, treatment monitoring, and often significant drug acquisition costs. That mix makes it very different from routine behavioral health billing.
Practices searching for a top Spravato billing company in the U.S. should look for a partner that understands the full patient and revenue workflow, not just claim submission. The best Spravato billing company for your practice should help you prevent revenue problems before they turn into denials.
Yes. Any healthcare setting administering SPRAVATO must meet the applicable REMS requirements.
Many payers require it, but requirements vary by plan. Benefits should be verified before treatment begins.
It depends on payer rules, acquisition cost, reimbursement timelines, patient volume, and available cash flow.
Before the first treatment. Billing should be part of the launch plan, not something you figure out afterward.
Yes. Finnastra supports new Spravato programs with REMS enrollment support, payer readiness, eligibility verification, prior authorization, credentialing, billing setup, and ongoing revenue cycle management.
A successful Spravato treatment program takes more than clinical readiness. REMS, staffing, payer setup, medication access, prior authorization, billing, and AR all have to work together from day one.
Finnastra’s Spravato billing services are designed to simplify that process. If you are planning to start a Spravato program, Finnastra can help you build the financial and administrative infrastructure you need, from setup through reimbursement.
